Baidu
map

国家中医药管理局加强中医药特色诊疗技术推广

2018-06-24 宫晓倩 新华网

近日,由国家中医药管理局举办的“中医药特色诊疗技术相关情况新闻通气会”在北京召开。会上,国家中医药管理局副局长王志勇表示,“中医药在疾病治疗领域有着独特疗效,我们要把祖先留给我们的中医药宝贵财富发展好、利用好,把真正好的中医药诊疗技术进行推广。”

近日,由国家中医药管理局举办的“中医药特色诊疗技术相关情况新闻通气会”在北京召开。会上,国家中医药管理局副局长王志勇表示,“中医药在疾病治疗领域有着独特疗效,我们要把祖先留给我们的中医药宝贵财富发展好、利用好,把真正好的中医药诊疗技术进行推广。”

中医药是中华民族的瑰宝,不仅在养生保健和慢性病调理方面具有优势,在急性疾病治疗中同样具有独特的优势。在王志勇看来,中医药大体可以分为三类,第一类是对疾病立竿见影的中医药技术;第二类是在费用、减少创伤等方面具有无法比拟优势的中医药技术;第三类是需要长期坚持才能够看到效果的养生保健方法和理念。

近年来,在全国开展的中医药传统知识调查中,发现了我国许多独具特色和确有疗效的诊疗技术。王志勇表示,“作为行业管理部门,我们有责任替老百姓把好关,在技术研究和评价的基础上,将好的中医药诊疗技术持续向社会推广。”

据了解,国家中医药管理局一直以来非常重视中医药特色诊疗技术的收集、整理,开展了百项中医临床诊疗技术的整理研究,本着简便、有效、安全和经济的原则,筛选了一百余项中医临床适宜技术并加以推广。通气会上,以“荆氏疗法”为例,介绍了中医特色诊疗技术。此次推广是国家中医药管理局挖掘中医药特色诊疗技术的新探索。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2045709, encodeId=8ef02045e0949, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Oct 22 07:45:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771275, encodeId=49cb1e71275ff, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Feb 12 02:45:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409593, encodeId=2c4c1409593c1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587372, encodeId=f332158e372e7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326864, encodeId=aada32686427, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:40:51 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326857, encodeId=381532685ec7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 25 09:03:15 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326598, encodeId=a2d5326598f4, content=好好文章学习好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:53:18 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2045709, encodeId=8ef02045e0949, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Oct 22 07:45:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771275, encodeId=49cb1e71275ff, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Feb 12 02:45:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409593, encodeId=2c4c1409593c1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587372, encodeId=f332158e372e7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326864, encodeId=aada32686427, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:40:51 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326857, encodeId=381532685ec7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 25 09:03:15 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326598, encodeId=a2d5326598f4, content=好好文章学习好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:53:18 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2045709, encodeId=8ef02045e0949, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Oct 22 07:45:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771275, encodeId=49cb1e71275ff, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Feb 12 02:45:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409593, encodeId=2c4c1409593c1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587372, encodeId=f332158e372e7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326864, encodeId=aada32686427, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:40:51 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326857, encodeId=381532685ec7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 25 09:03:15 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326598, encodeId=a2d5326598f4, content=好好文章学习好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:53:18 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-06-25 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=2045709, encodeId=8ef02045e0949, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Oct 22 07:45:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771275, encodeId=49cb1e71275ff, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Feb 12 02:45:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409593, encodeId=2c4c1409593c1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587372, encodeId=f332158e372e7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326864, encodeId=aada32686427, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:40:51 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326857, encodeId=381532685ec7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 25 09:03:15 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326598, encodeId=a2d5326598f4, content=好好文章学习好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:53:18 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2045709, encodeId=8ef02045e0949, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Oct 22 07:45:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771275, encodeId=49cb1e71275ff, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Feb 12 02:45:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409593, encodeId=2c4c1409593c1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587372, encodeId=f332158e372e7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326864, encodeId=aada32686427, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:40:51 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326857, encodeId=381532685ec7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 25 09:03:15 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326598, encodeId=a2d5326598f4, content=好好文章学习好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:53:18 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-06-25 139****5926

    好好文章学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2045709, encodeId=8ef02045e0949, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Oct 22 07:45:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771275, encodeId=49cb1e71275ff, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Feb 12 02:45:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409593, encodeId=2c4c1409593c1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587372, encodeId=f332158e372e7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326864, encodeId=aada32686427, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:40:51 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326857, encodeId=381532685ec7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 25 09:03:15 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326598, encodeId=a2d5326598f4, content=好好文章学习好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:53:18 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-06-25 明月清辉

    谢谢分享.学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2045709, encodeId=8ef02045e0949, content=<a href='/topic/show?id=337e9169582' target=_blank style='color:#2F92EE;'>#诊疗技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91695, encryptionId=337e9169582, topicName=诊疗技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Mon Oct 22 07:45:00 CST 2018, time=2018-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771275, encodeId=49cb1e71275ff, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Feb 12 02:45:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409593, encodeId=2c4c1409593c1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587372, encodeId=f332158e372e7, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Mon Jun 25 23:45:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326864, encodeId=aada32686427, content=好好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:40:51 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326857, encodeId=381532685ec7, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Mon Jun 25 09:03:15 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326598, encodeId=a2d5326598f4, content=好好文章学习好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:53:18 CST 2018, time=2018-06-24, status=1, ipAttribution=)]
    2018-06-24 139****5926

    好好文章学习好文章

    0

相关资讯

国家中医药管理局发布《关于加快中医药科技创新体系建设的若干意见》

各省、自治区、直辖市中医药管理局,各有关单位:为进一步加强中医药(民族医药)科技创新能力建设,提升科技创新对中医药事业发展的支撑引领作用和对经济社会发展的贡献率,根据《中共中央 国务院关于深化科技体制改革加快国家创新体系建设的意见》、《中共中央 国务院关于深化体制机制改革加快实施创新驱动发展战略的若干意见》、《中医药发展战略规划纲要(2016-2030年)》以及全国科技创新大会和全国卫生与健康

国家中医药管理局致全国中医护理工作者的慰问信

中医护理是中医药事业的重要组成部分,与中医学同步产生和发展,在长期的临床实践过程中,形成了以整体观念为指导,以中医辨证理论为依据,融传统与现代护理技术为一体的独特的中医护理理论体系和技术操作系统,已经成为中医药综合防治疾病的重要手段之一。中医药系统的护理工作者坚持以人民为中心,牢记南丁格尔誓言,弘扬“敬佑生命、救死扶伤、甘于奉献、大爱无疆”的精神,以忠诚的服务理念、严谨的工作作风和精湛的专业技术,

国家中医药管理局举办中医药系统现代医院管理制度培训

11月22日,国家中医药管理局在广东省广州市举办中医药系统现代医院管理制度培训班。国家中医药管理局副局长、局医改领导小组副组长、医改办主任马建中出席培训班并做重要讲话。各省(区、市)中医药管理部门负责同志、中国中医科学院有关负责同志、国家中医药管理局属管医院主要负责同志、各省(区、市)省级中医医院和公立医院综合改革国家级示范城市辖区内的1家三级公立中医医院主要负责同志参加了培训。培训班由国家中医药

国家中医药管理局与湖北省政府签署合作协议:推进湖北建设中医药强省

6月5日,国家中医药管理局与湖北省人民政府在湖北武汉签署了《推进湖北建设中医药强省合作框架协议》。根据协议,双方将在中医医院建设发展、中医药服务能力提升、中医药人才队伍建设、中医药产业发展、中医药文化等五个方面进一步深化战略合作。

王国强:在深化医改中切实发挥中医药作用

  11月16日,国家中医药管理局召开会议传达贯彻党的十八大精神。卫生部副部长,国家中医药管理局党组书记、局长王国强要求全国中医药系统以十八大精神为指导,全面开创新时期中医药工作新局面,在深化医改中切实发挥中医药的作用,为提高人民群众健康水平、实现全面建成小康社会的宏伟目标作出更大贡献。   王国强要求,中医药系统全体同志必须更加坚定、更加自觉地将科学发展观贯彻到中医药改革发展的各个方面、各个环

国家中医药管理局召开干部大会

国家中医药管理局召开干部大会,通报了中央关于王国强不再担任国家中医药管理局党组书记、局长的决定,国家卫生健康委员会党组研究决定由委党组成员、副主任曾益新分管国家中医药管理局,国家中医药管理局党组成员、副局长马建中负责局日常工作。曾益新、王国强出席会议并讲话,马建中主持会议。

Baidu
map
Baidu
map
Baidu
map